Nutra Pharma Corp. (NPHC)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
-0.0002 (-66.67%)
May 7, 2025, 4:00 PM EDT
Nutra Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | 2012 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '22 Sep 30, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | 2012 - 2016 |
| Revenue | 0.25 | 0.1 | 0.05 | 0.1 | 0.13 | 0.12 | Upgrade
|
| Revenue Growth (YoY) | 185.06% | 88.33% | -50.29% | -20.06% | 7.95% | -28.14% | Upgrade
|
| Cost of Revenue | 0.18 | 0.09 | 0.04 | 0.07 | 0.12 | 0.03 | Upgrade
|
| Gross Profit | 0.07 | 0.01 | 0.01 | 0.03 | 0.01 | 0.09 | Upgrade
|
| Selling, General & Admin | 1.42 | 1.93 | 1.1 | 1.2 | 1.39 | 1.48 | Upgrade
|
| Operating Expenses | 1.45 | 2 | 0.94 | 1.26 | 1.89 | 1.48 | Upgrade
|
| Operating Income | -1.38 | -1.99 | -0.92 | -1.23 | -1.88 | -1.38 | Upgrade
|
| Interest Expense | -0.73 | -0.5 | -0.34 | -0.26 | -0.59 | -0.36 | Upgrade
|
| Other Non Operating Income (Expenses) | 9.38 | -10.13 | -1.1 | -5.19 | -2.32 | -2.27 | Upgrade
|
| EBT Excluding Unusual Items | 7.27 | -12.61 | -2.36 | -6.68 | -4.79 | -4.01 | Upgrade
|
| Other Unusual Items | -0.15 | -0.49 | 1.59 | 0.09 | 0.91 | -0.01 | Upgrade
|
| Pretax Income | 7.11 | -13.1 | -0.77 | -6.59 | -3.88 | -4.03 | Upgrade
|
| Net Income | 7.11 | -13.1 | -0.77 | -6.59 | -3.88 | -4.03 | Upgrade
|
| Net Income to Common | 7.11 | -13.1 | -0.77 | -6.59 | -3.88 | -4.03 | Upgrade
|
| Shares Outstanding (Basic) | 7,435 | 7,233 | 6,607 | 4,710 | 3,187 | 1,048 | Upgrade
|
| Shares Outstanding (Diluted) | 13,160 | 7,233 | 6,607 | 4,710 | 3,187 | 1,048 | Upgrade
|
| Shares Change (YoY) | 84.73% | 9.46% | 40.28% | 47.78% | 204.05% | 522.29% | Upgrade
|
| EPS (Basic) | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Free Cash Flow | -1 | -1.78 | -0.88 | -0.74 | -1 | -1.15 | Upgrade
|
| Free Cash Flow Per Share | - | - | - | - | - | -0.00 | Upgrade
|
| Gross Margin | 26.85% | 8.66% | 28.74% | 33.25% | 10.77% | 77.76% | Upgrade
|
| Operating Margin | -557.88% | -2034.53% | -1782.27% | -1178.14% | -1438.68% | -1142.30% | Upgrade
|
| Profit Margin | 2871.21% | -13399.01% | -1482.14% | -6314.07% | -2974.59% | -3330.12% | Upgrade
|
| Free Cash Flow Margin | -405.36% | -1824.84% | -1703.36% | -712.37% | -765.68% | -948.48% | Upgrade
|
| EBITDA | -1.36 | -1.98 | -0.92 | -1.23 | -1.87 | -1.38 | Upgrade
|
| D&A For EBITDA | 0.02 | 0.01 | 0 | 0 | 0.01 | 0.01 | Upgrade
|
| EBIT | -1.38 | -1.99 | -0.92 | -1.23 | -1.88 | -1.38 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.